Cobicistat
Drug ingredientCAS 1004316-88-4
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownProduction is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.
Where It Comes From
Customs basis: HS 293410 · basket
These shares come from HS customs code 293410, which covers 83 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.
- United Kingdom
- Italy
- Ukraine
- Spain
- Netherlands
- Poland
- Belgium
- Canada
- Croatia
- Bulgaria
- Taiwan
- Sweden
- Slovakia
- Slovenia
11 FDA-registered drug labelers
Why It Matters
Appears in 7 drug and cosmetic product listings (FDA).
- •Prezcobix
- •Genvoya
- •Prezcobix PED
- •Stribild
- •Tybost
- •Symtuza
- •Evotaz
- to be discontinued
Cobicistat Tablet
Shortage listed since October 7, 2025
- to be discontinued
Atazanavir Sulfate; Cobicistat Tablet
Shortage listed since November 3, 2025
Vendor Pricing
Prices reflect listed pack sizes. Small research packs run far above bulk rates.
15 more vendors
| Vendor | Country Supplier country. Where available, shows shipping origin. When the supplier ships from a different country than where they are registered, both are shown. Most suppliers show registration country only. | $/g | Pack | Purity |
|---|---|---|---|---|
| MedKoo Biosciences, Inc | United States | $3250.00 | 1 g | 98% |
| Angene Chemical | China → Hong Kong | $4014.00 | 1 g | 98% |
| A2B Chem LLC | United States | $4090.00 | 100 mg | 98% |
| BLD Pharmatech Ltd. | China | $4384.00 | 250 mg | 98% |
| Aaron Chemicals LLC | Hong Kong | $4388.00 | 250 mg | 98% |
| AA BLOCKS | United States | $4450.00 | 100 mg | 98% |
| Molnova | China | $4780.00 | 100 mg | 99% |
| AstaTech, Inc | United States | $4970.00 | 100 mg | 95% |
| TargetMol Chemicals | China → United States | $5310.00 | 100 mg | 99.62% |
| Apexbio Technology LLC | United States | $6050.00 | 200 mg | 99.94% |
| MedChemExpress MCE | Sweden | $8941.90 | 100 mg | 99.77% |
| Angene International Limited | United States | $11820.00 | 100 mg | 98% |
| BLD Pharmatech Co., Limited | United States | $12100.00 | 10 mg | 98% |
| BLD Pharmatech GmbH | Germany | $12100.00 | 10 mg | 98% |
| Cayman Europe | Estonia | $36176.00 | 25 mg | 98% |
Chemical Identity
Data Sources
- PubChem · compound 25151504Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA Drug ShortagesRetrieved 2026-10-04
- US Census international tradeReporting year: 2024 · Retrieved 2026-10-04
Brief citations
Cobicistat (CAS 1004316-88-4) https://chemicalindependence.com/chemical/1004316-88-4/ PubChem: 25151504. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/25151504 FDA National Drug Code directory: CAS 1004316-88-4. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 1004316-88-4. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293410 for CAS 1004316-88-4. Reporting year: 2024. https://usatrade.census.gov/